This application claims priority to Chinese Patent Application No. 202310740737.6, filed on Jun. 20, 2023, which is incorporated herein by reference in its entirety.
The present application relates to the technical field of mosquito prevention and control, in particular to a composite multi-effect mosquito prevention and control apparatus.
The problem of mosquito repelling is one of problems that may not be ignored in people's daily life. An electric heating mosquito repelling device used in combination with drugs is one of common mosquito prevention and control devices. In existing technologies, the electric heating mosquito repelling device is unusually provided with only one heating zone and suitable for the use in combination with a drug with a specific component. However, for drugs commonly used for mosquito repelling and mosquito killing, various components therein have different optimal working temperatures, due to its single heating zone, it may only rely on one of the mosquito repelling drug and the mosquito killing drug to play a separate role in repelling or killing mosquitoes at the same time, and other drugs in the drug may only be used in small quantities as auxiliary drugs because they are not at the optimal working temperatures, thus the combined effect of the drugs with different types and functions in repelling and killing the mosquitoes may not be achieved.
The present application provides a composite multi-effect mosquito prevention and control apparatus, as to solve a problem that electric heating mosquito repelling devices in existing technologies may not achieve the combined effect of drugs with different types and functions in repelling and killing mosquitoes.
In order to achieve the above purpose, the present application adopts the following technical schemes:
Further, a first information display area and a second information display area are respectively arranged below the first heating zone and the second heating zone on the apparatus housing; and
Further, the first information display area and the second information display area are each provided with a display screen or a plurality of indicator lights.
Further, the working temperature of the second heating zone is greater than 40° C. and less than 120° C.
Further, the apparatus housing is further provided with a human-machine interaction area, and the human-machine interaction area is used to control a switch of the composite multi-effect mosquito prevention and control apparatus and adjust the temperatures of the first heating zone and the second heating zone.
Further, the first heating zone and the second heating zone are both provided with a multi-level temperature gear, the human-machine interaction area is provided with a plurality of adjustment buttons, and the human-machine interaction area may adjust the temperature gears of the first heating zone and the second heating zone.
Further, the second drug installed in the second heating zone is gel-like or paste-like, which is formed by mixing the repellent agent and a carrier.
Further, the second drug installed in the second heating zone is tablet-like, which is formed by mixing the repellent agent and a coating agent, and pressing after drying.
Further, the second heating zone is provided with an installation groove for installing the second drug.
Further, the second drug installed in the second heating zone is prepared by an adsorbent material carrying the repellent agent.
The beneficial effects of the present application are as follows.
The present application heats the drug containing different main acting agents according to its optimal working temperature by setting the first heating zone and the second heating zone with different temperature ranges, so that the apparatus of the present application may simultaneously diffuse different mosquito prevention and control agents at the different optimal working temperatures, to achieve the composite multi-effect mosquito prevention and control effect.
In order to make purposes, technical schemes, and advantages of the present application clearer, the technical schemes of the present application are further clearly and completely described below in combination with embodiments of the present application. It should be noted that the embodiments described are only a part of the embodiments of the present application, not all of the embodiments. Based on the embodiments in the present application, all other embodiments obtained by those of ordinary skill in the art without creative labor shall fall within the scope of protection of the present application.
It should be noted that if a directional indication (such as up, down, left, right, front, back, top, bottom, inside, outside, vertical, horizontal, longitudinal, counterclockwise, clockwise, circumferential, radial, and axial) is involved in the embodiments of the present application, the directional indication is only used to explain a relative position relationship, a motion situation and the like between various components in a specific posture (as shown in the drawings). If the specific posture is changed, the directional indication is also changed accordingly with it.
The term “and/or” in the embodiments of the present application is only a description of an association relationship of associated objects, it is indicated that there may be three types of relationships, for example, A and/or B, it may indicate: the existence of A alone, the existence of A and B simultaneously, and the existence of B alone.
The terms “first” and “second” in the embodiments of the present application are only used for descriptive purposes and may not be understood as indicating or implying the relative importance or implying the quantity of technical features indicated. Therefore, features limited to “first” and “second” may explicitly or implicitly include at least one of these features. In the description of the present application, the terms “including” and “having” and any variations thereof are intended to cover non-exclusive inclusion. For example, a system, a product, or a device that contains a series of components or units is not limited to the listed components or units, but optionally includes unlisted components or units, or optionally includes other components or units inherent to these products or devices. In the description of the present application, “plurality” means at least two, for example two and three, unless otherwise specified.
The reference to “embodiments” in this article means that specific features, structures, or characteristics described in combination with the embodiments may be contained in at least one embodiment of the present application. The phrase appearing in various positions in the description does not necessarily refer to the same embodiment, nor is it an independent or alternative embodiment that is mutually exclusive with other embodiments. Those skilled in the art explicitly and implicitly understand that the embodiments described in this article may be combined with other embodiments.
As shown in
Below the first information display area 4 and the second information display area 5, a human-machine interaction area 6 is arranged, and a plurality of buttons is arranged in the human-machine interaction area 6, as to control a switch of the apparatus and a specific temperature gear.
The drug 1 includes a first drug 11 and a second drug 12, and the first drug 11 and the second drug 12 are both in the form of tablet-like, gel-like or paste-like; the first drug 11 is installed in the first heating zone 2, and the first drug contains pyrethroid; and the second drug 12 is installed in the second heating zone 3, and the second drug 12 contains a repellent agent.
The first heating zone 2 and the second heating zone 3 are provided with an installation groove to fasten the drug (namely the first drug 11 and the second drug 12). The agents contained in the drug of the present application mainly include the pyrethroid drug that has a mosquito killing effect, and the repellent agent that has a mosquito repelling effect, including picaridin (also known as icaridin), ethyl butylacetylaminopropionate (also known as BAAPE, mosquito repellents, scientific name: 3-(N-acetyl-N-butyl)aminopropionic acid ethyl ester), DEET, and methyl nonylketone.
In order to achieve the composite mosquito prevention and control effect, in the present application, the main component of the first drug 11 adapted to the first heating zone 2 is set as the pyrethroid, and the main component of the second drug 12 adapted to the second heating zone 3 is set as the repellent agent (such as the picaridin, ethyl butylacetylaminopropionate, DEET, and methyl nonylketone). The working temperature of the second heating zone 3 is set to be greater than 40° C. and less than 120° C., to achieve the better diffusion effect of the repellent agent. In addition, the first heating zone 2 and the second heating zone 3 are both provided with a plurality of temperature gears, and the gears are adjusted by operating in the human-machine interaction area 6.
For the second drug 12 of the second heating zone 3, in an embodiment of the present application, the second drug 12 of the second heating zone 3 is in the form of gel-like, and is prepared by the following method:
In another embodiment of the present application, the second drug 12 in the second heating zone 3 is in the form of paste-like, and is prepared by the following method:
In another embodiment of the present application, the second drug 12 in the second heating zone 3 is prepared by an adsorbent material (such as flexible non-woven fabric) carrying the repellent agent.
In another embodiment of the present application, the second drug 12 in the second heating zone 3 is in the form of tablet-like, and it may be formed by mixing the repellent agent and a coating agent agent (such as crown ether, cyclodextrin, calixarene, calixpyrrole, calixazole, cucurbituril, and pillararene) and drying to form a solid, and then pressing into a tablet. In this embodiment, the second heating zone 3 may be provided with an installation groove for accommodating the second drug 12, thereby the second drug 12 is installed in the second heating zone 3.
The present application heats the drug containing different main acting agents according to its optimal working temperature by setting the first heating zone 2 and the second heating zone 3 with different temperature ranges, so that the apparatus of the present application may simultaneously diffuse mosquito prevention and control agents with different types and functions at the different optimal working temperatures, to achieve the composite multi-effect mosquito prevention and control effect.
The above embodiments only express implementation modes of the present application, and its description is more specific and detailed, but may not be understood as limitations on the scope of the present application. It should be pointed out that for those of ordinary skill in the art, a plurality of modifications and improvements may also be made without departing from the concept of the present application, all of which shall fall within the scope of protection of the present application. Therefore, the scope of protection of the present application should be based on the appended claims.
Number | Date | Country | Kind |
---|---|---|---|
202310740737.6 | Jun 2023 | CN | national |